SpyGlass Pharma (SGP) Net Cash Flow (2025 - 2026)
SpyGlass Pharma (SGP) reported Net Cash Flow of $80.09 million for FY2025, compared with $419,000 in FY2024.
Powered by 
Analysis
SpyGlass Pharma (SGP) Net Cash Flow (2025 - 2026) Analysis & Trends
- According to Business Quant data, Net Cash Flow came in at $419,000 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -4.12 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 4.21 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.81 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -799.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.26 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 843.00 Mn |
| 10 | SpyGlass Pharma | 1.25 Bn | 636.40 Mn | - | -15.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.78 Mn |
| Mar 31, 2026 | 142.54 Mn |
| Jun 30, 2025 | 69.24 Mn |
| Mar 31, 2025 | 41.73 Mn |
API Access
SpyGlass Pharma Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SGP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "SGP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SGP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();